| 000 | 01708 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516135342.0 | ||
| 264 | 0 | _c20140820 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1553-7374 | ||
| 024 | 7 |
_a10.1371/journal.ppat.1003187 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkalska, Lenka | |
| 245 | 0 | 0 |
_aInduction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. _h[electronic resource] |
| 260 |
_bPLoS pathogens _cFeb 2013 |
||
| 300 |
_ae1003187 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigens, Viral _xgenetics |
| 650 | 0 | 4 |
_aB-Lymphocytes _xvirology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xgenetics |
| 650 | 0 | 4 |
_aEpigenetic Repression _xgenetics |
| 650 | 0 | 4 |
_aEpstein-Barr Virus Infections _ximmunology |
| 650 | 0 | 4 |
_aEpstein-Barr Virus Nuclear Antigens _xgenetics |
| 650 | 0 | 4 | _aGenetic Loci |
| 650 | 0 | 4 |
_aHerpesvirus 4, Human _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 | _aVirus Latency |
| 700 | 1 | _aWhite, Robert E | |
| 700 | 1 | _aParker, Gillian A | |
| 700 | 1 | _aTurro, Ernest | |
| 700 | 1 | _aSinclair, Alison J | |
| 700 | 1 | _aPaschos, Kostas | |
| 700 | 1 | _aAllday, Martin J | |
| 773 | 0 |
_tPLoS pathogens _gvol. 9 _gno. 2 _gp. e1003187 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.ppat.1003187 _zAvailable from publisher's website |
| 999 |
_c22530661 _d22530661 |
||